FDA Grants Orphan Drug Status to INN-108 as an Ulcerative Colitis Therapy for Children
News
The U.S. Food and Drug Administration has granted orphan drug status to INN-108 as a treatment for children with ulcerative colitis, its maker, Innovate Biopharmaceuticals, announced in a press release. Regulators grant orphan drug designation to treatments ... Read more